Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma

Area of Science:

• Oncology
• Genetics
• Dermatology

Background:

• Germline mutations in the telomerase reverse transcriptase (TERT) gene core promoter region were previously identified in melanoma families.
• Recurrent somatic mutations in the TERT promoter were also found in metastatic tumors from unrelated patients.

Purpose of the Study:

• To investigate the association of TERT promoter mutations with clinical and pathological features of primary melanomas.
• To determine the frequency and co-occurrence of TERT promoter mutations with other known melanoma-associated alterations.

Main Methods:

• Analysis of TERT promoter mutations in 287 primary melanoma samples.
• Correlation of mutation status with patient age, Breslow thickness, tumor ulceration, and sun exposure sites.
• Assessment of co-occurrence with BRAF and CDKN2A alterations.

Main Results:

• TERT promoter mutations were associated with increased patient age, Breslow thickness, and tumor ulceration.
• Mutations were more frequent in sun-exposed areas and co-occurred with BRAF and CDKN2A alterations.
• TERT promoter mutations were linked to increased TERT gene expression.

Conclusions:

• TERT promoter mutations in primary melanomas are associated with adverse prognostic factors.
• These mutations may play a significant role in melanoma development and progression.
• TERT promoter mutations show potential for use in melanoma disease management.